Artificial Intelligence in Breast Cancer Screening: Trial Shows Reduction in Radiologist Workload

Artificial Intelligence (AI) can reduce the workload of radiologists by almost half in breast cancer screening, according to the world’s largest trial of its kind. The trial, which involved over 80,000 women in Sweden, compared AI-supported screening with standard care. The use of AI did not increase false-positive results and was as effective as two radiologists working together. Furthermore, there was a 44% reduction in the screen-reading workload for radiologists in the AI group. The final results of the trial, including whether AI can reduce the number of interval cancers, are expected in the coming years. However, the interim analysis concludes that the use of AI in mammography screening is safe. The lead author of the study suggests that AI could potentially alleviate the burden on radiologists and reduce waiting times for patients. While the study received praise for its quality, concerns were raised regarding the potential overdiagnosis of less harmful lesions. Breast Cancer Now, a charity, stated that the final trial results would determine whether AI could improve breast cancer screening. The NHS in England welcomed the research and is exploring how AI can speed up diagnosis and save lives. The Royal College of Radiologists also expressed optimism about AI’s potential to support decision-making and prioritize urgent cases.